Your session is about to expire
← Back to Search
Optical Biopsy System
ClariCore System for Prostate Cancer
N/A
Waitlist Available
Research Sponsored by Precision Biopsy, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30 days post-procedure
Awards & highlights
Study Summary
The purpose of the study is to collect information on prostrate biopsy tissue for use in developing a method determining the difference in normal and cancerous prostrate tissue using the ClariCore System.
Eligible Conditions
- Prostate Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ ath the time of procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~ath the time of procedure
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Primary Effectiveness
Secondary outcome measures
Assessment of Pain
Incidence and frequency of adverse events
Other outcome measures
Clinical Success
Negative Predictive Value
Technical Success
Trial Design
1Treatment groups
Experimental Treatment
Group I: ClariCore SystemExperimental Treatment1 Intervention
ClairCore System study designed for data collection to build the prostrate tissue classification algorithm.
Find a Location
Who is running the clinical trial?
Precision Biopsy, Inc.Lead Sponsor
3 Previous Clinical Trials
485 Total Patients Enrolled
2 Trials studying Prostate Cancer
160 Patients Enrolled for Prostate Cancer
Sierra YearlyStudy DirectorSponsor GmbH
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger